omniture
杭州启明医疗器械股份有限公司VENUS MEDTECH (HANGZHOU) INC.

Latest News

Venus Medtech Launches Global Advisory Board to Target for International Market

SAN DIEGO, Sept. 25, 2018 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc., a Chinese medical device ...

2018-09-25 00:00 877

Venus Medtech Enters North American Market

HANGZHOU, China and VANCOUVER, Canada, June 14, 2018 /PRNewswire/ -- On June 12, 2018, St Paul 's H...

2018-06-14 13:12 1563

Venus Medtech's strategic investment in Keystone Heart deepens the technical layout of cerebral embolic protection market

HANGZHOU, China, May 24, 2018 /PRNewswire/ -- China Venus Medtech (Hangzhou) Inc. announced a part...

2018-05-24 01:14 1257

Venus Medtech Receives DCP Capital's Equity Investment to Accelerate Heart Valve Technology Development and International Commercialization

HANGZHOU, China, May 16, 2018 /PRNewswire/ -- Venus Medtech announced that it has entered into a ...

2018-05-16 10:05 1209

First Successful Clinical Implantation of Transcatheter Pulmonary Valve VenusP-Valve was Successfully Completed in Brazil

SAO PAULO, Dec. 23, 2017 /PRNewswire/ -- On December 19, 2017, local time, 4 clinical implantations...

2017-12-23 02:02 6428

China successfully completes the country's first human implantation of a retrievable transcatheter aortic valve

HANGZHOU, China, Nov. 28, 2017 /PRNewswire/ -- The first human implantation of the VenusA Plus retr...

2017-11-28 21:00 825

Venus Medtech Acquires U.S. Company InterValve to Create a Systematic TAVR Treatment and Strengthen Global Expansion

HANGZHOU, China, June 14, 2017 /PRNewswire/ -- Venus Medtech announced on June 13, 2017 that it has...

2017-06-14 22:21 2517

Venus Medtech's TAVR Device Is Approved By CFDA, Creating A New Era Of Interventional Cardiology In China

HANGZHOU, China, April 28, 2017 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc., announced onApril 25...

2017-04-28 21:45 4029

The Successful Worldwide First in Human Implantation of an Innovative Aortic Valve from Colibri Heart Valve and Venus Medtech with Disruptive "Dry Tissue" Technology Conducted

CORRIENTES, Argentina and HANGZHOU, China, Oct. 27, 2016 /PRNewswire/ -- The joint venture entity (J...

2016-10-28 10:42 1791

Venus Medtech's Transcatheter Pulmonary Valve Debuts in Europe, Marking the Start of Global Clinical Trial

LONDON and HANGZHOU, China, Sept. 19, 2016 /PRNewswire/ -- Venus P, the transcatheter pulmonary valv...

2016-09-19 13:18 1512

First Ever Venus P-Valve Implantations in Latin America

HANGZHOU, China, April 6, 2016 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. has achieved another im...

2016-04-06 21:10 1711

Venus Medtech Receives Investment from Goldman Sachs, and Establishes Cardiac Valve Research Institute Together with the Second Affiliated Hospital of Zhejiang University

HANGZHOU, China, March 25, 2016 /PRNewswire/ -- The Cardiac Valve Research Institute ("the Institut...

2016-03-25 15:03 3229